论文部分内容阅读
调查在河北省石家庄市区冠心病和缺血性脑血管病二级预防中阿司匹林的应用状况。通过对原住院患者随访,对内科门诊、专家门诊和社区门诊患者通过问卷调查,收集服用阿司匹林的有关资料,根据阿司匹林的应用情况,将患者分为两组:1组为服药组:患者规范或不规范服用阿司匹林;2组为未用药组:患者从未服阿司匹林。共1 885例,其中缺血性脑血管病925例、冠心病711例、冠心病与缺血性脑血管病并存249例。患者来自住院随访患者567例、内科门诊882例、社区门诊436例。全组1 885例患者中,服用阿司匹林组为1 226例(占比例为65.1%),其中,规范服用阿司匹林957例(50.8%),不规范用药269例(14.3%),未服用阿司匹林659例(34.9%)。阿司匹林在本调查地区缺血性心脑血管病二级预防中的应用率较高,用药的依从性较好,但和阿司匹林规范化应用的专家共识还有较大的差距。
To investigate the application of aspirin in secondary prevention of coronary heart disease and ischemic cerebrovascular disease in Shijiazhuang City, Hebei Province. According to the application of aspirin, the patients were divided into two groups according to the application of aspirin: group 1 was the medication group: the patients ’norms or the patients’ Non-standard aspirin; 2 groups were not medication group: patients never take aspirin. A total of 1 885 cases, of which 925 cases of ischemic cerebrovascular disease, 711 cases of coronary heart disease, coronary heart disease and ischemic cerebrovascular disease co-exist in 249 cases. Patients were from hospitalized follow-up patients 567 cases, 882 cases of internal medicine clinic, community clinics 436 cases. Of the 1885 patients who took aspirin, 1,226 (65.1%) took aspirin, among which 957 were aspirin (50.8%), 269 (14.3%) were non-standard, 659 were not aspirin (34.9%). Aspirin has a higher rate of application in the secondary prevention of ischemic cardiovascular and cerebrovascular diseases in this survey area and the compliance of medication is better. However, there is still a big gap between experts and aspirin standardization experts.